Sun Pharma Advanced Research Company has informed that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the Company’s Code of Conduct for Prevention of Insider Trading (the CoC), the Trading Window for trading in shares of the Company shall remain closed with effect from Tuesday, April 1, 2025 till 48 hours after the declaration of Audited Financial Results of the Company for the financial year ended March 31, 2025. The date of Board Meeting to approve the Audited Financial Results of the Company for the financial year ended March 31, 2025 shall be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
